# Sodium Lactate and Brain Relaxation (LSD)

> **NCT04488874** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 50 (actual)

## Conditions studied

- Sodium Lactate
- Intracranial Hypertension
- Brain Relaxation

## Interventions

- **DRUG:** Sodium Lactate
- **DRUG:** Mannitol 20% Infusion

## Key facts

- **NCT ID:** NCT04488874
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04488874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04488874, "Sodium Lactate and Brain Relaxation (LSD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04488874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*